Literature DB >> 23816930

Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer.

Zeng-Zhen Lai1, Xiao-Ling Pan, Liang Song.   

Abstract

OBJECTIVES: To investigate the association between toll-like receptor 9 (TLR9) single nucleotide polymorphisms (SNPs) and human papillomavirus (HPV) infection among Chinese Han women with cervical cancer.
METHODS: TLR9 -1486 and 2848 SNPs were investigated in patients with cervical cancer and controls using polymerase chain reaction (PCR)-restriction fragment length polymorphism. HPV16 E6 and E7 infections were assessed using PCR.
RESULTS: Of 120 patients with cervical cancer and 100 controls, there was a significant association between TLR9 2848 SNP and cervical cancer risk, but there was no such association with TLR9 -1486 SNP. Frequency of the TLR9 2848 GA genotype was significantly higher in patients with cervical cancer than in controls. There was no statistically significant between-group difference in presence of HPV16 infection. Presence of HPV infection with TLR9 2848 (rs352140) GA/AA genotype increased the risk of cervical cancer 13.8-fold compared with the GG genotype.
CONCLUSIONS: The TLR9 2848 G/A polymorphism in Chinese Han women was associated with increased risk of cervical cancer in the presence of HPV16 infection. Further studies are necessary to uncover the functional aspect of this TLR9 2848 polymorphism.

Entities:  

Keywords:  Human papillomavirus (HPV); Toll-like receptor 9 (TLR9); cervical cancer; gene polymorphism; rs352140; single nucleotide polymorphism (SNP)

Mesh:

Substances:

Year:  2013        PMID: 23816930     DOI: 10.1177/0300060513483398

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  13 in total

1.  The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.

Authors:  Shasha Yang; Lan Liu; Dongyuan Xu; Xiangdan Li
Journal:  Pathol Oncol Res       Date:  2018-09-13       Impact factor: 3.201

2.  TLR9 2848 G/A Gene Polymorphism in HCV+, HIV+, and HCV+/HIV+ Individuals.

Authors:  Bruna Kulmann-Leal; Joel Henrique Ellwanger; Jacqueline María Valverde-Villegas; Daniel Simon; Camila Guerra Marangon; Vanessa Suñé Mattevi; Rosmeri Kuhmmer Lazzaretti; Regina Kuhmmer; Eduardo Sprinz; José Artur Bogo Chies
Journal:  Genet Test Mol Biomarkers       Date:  2022-05-16

3.  TLR9 -1486T/C and 2848C/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants.

Authors:  Edyta Paradowska; Agnieszka Jabłońska; Mirosława Studzińska; Katarzyna Skowrońska; Patrycja Suski; Małgorzata Wiśniewska-Ligier; Teresa Woźniakowska-Gęsicka; Dorota Nowakowska; Zuzanna Gaj; Jan Wilczyński; Zbigniew J Leśnikowski
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

Review 4.  Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.

Authors:  Akash M Mehta; Merel Mooij; Ivan Branković; Sander Ouburg; Servaas A Morré; Ekaterina S Jordanova
Journal:  J Immunol Res       Date:  2017-02-09       Impact factor: 4.818

5.  Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.

Authors:  Nilesh O Pandey; Alex V Chauhan; Nitin S Raithatha; Purvi K Patel; Ronak Khandelwal; Ajesh N Desai; Yesha Choxi; Rutul S Kapadia; Neeraj D Jain
Journal:  Sci Rep       Date:  2019-07-05       Impact factor: 4.379

Review 6.  Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.

Authors:  Vince Kornél Grolmusz; Anikó Bozsik; János Papp; Attila Patócs
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

7.  Association of the polymorphism of the Toll-like receptor (TLR)-3 and TLR-9 genes with hepatitis C virus-specific cell-mediated immunity outcomes among Egyptian health-care workers.

Authors:  S F Abdelwahab; S Hamdy; A M Osman; Z A Zakaria; I Galal; M Sobhy; M Hashem; W R Allam; M Abdel-Samiee; E Rewisha; I Waked
Journal:  Clin Exp Immunol       Date:  2020-10-02       Impact factor: 4.330

8.  Essential role of HCMV deubiquitinase in promoting oncogenesis by targeting anti-viral innate immune signaling pathways.

Authors:  Puja Kumari; Irene Saha; Athira Narayanan; Sathish Narayanan; Akinori Takaoka; Nachimuthu Senthil Kumar; Prafullakumar Tailor; Himanshu Kumar
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469

9.  Absence of toll-like receptor 9 Pro99Leu polymorphism in cervical cancer.

Authors:  Alex Chauhan; Nilesh Pandey; Nitin Raithatha; Purvi Patel; Ajesh Desai; Neeraj Jain
Journal:  F1000Res       Date:  2018-05-17

Review 10.  The Associations between Toll-Like Receptor 9 Gene Polymorphisms and Cervical Cancer Susceptibility.

Authors:  Sijuan Tian; Liping Zhang; Ting Yang; Xing Wei; Li Zhang; Yang Yu; Yang Li; Di Cao; Xiaofeng Yang
Journal:  Mediators Inflamm       Date:  2018-07-25       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.